← Back
Data updated: Mar 10, 2026
HERITAGE PHARMS INC
Pharmaceuticals
HERITAGE PHARMS INC is a generic drug manufacturer with 8 FDA-approved products.
1972
Since
8
Drugs
-
Trials
29
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DUTASTERIDE 2025-08-15
Labeling
ETHOSUXIMIDE 2025-08-01
Labeling
ETHOSUXIMIDE 2025-08-01
Labeling
ALPRAZOLAM 2025-07-21
Labeling
ALPRAZOLAM 2025-07-21
Labeling
HYDRALAZINE HYDROCHLORIDE 2025-07-17
ALPRAZOLAM 2025-07-03
Labeling
HYDRALAZINE HYDROCHLORIDE 2025-06-02
HYDRALAZINE HYDROCHLORIDE 2025-04-21
Labeling
HYDRALAZINE HYDROCHLORIDE 2025-04-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (6)
Company Info
- First Approval
- 1972-09-15
- Latest
- 2023-10-06
- Applications
- 10
FDA Sponsor Names
HERITAGE PHARMS INCHERITAGE PHARMS LABS